PTC Therapeutics Reports First Quarter 2018 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to PTC Therapeutics Reports First Quarter 2018 Financial Results and Provides a Corporate Update

PTC Therapeutics (PTCT) PT Lowered to $30 at RBC Capital

May 10, 2018 8:51 AM EDT

RBC Capital lowered its price target on PTC Therapeutics (NASDAQ: PTCT) to $30.00 (from $31.00) while maintaining a Sector Perform rating.

... More